Clinical Trial

Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the safety and tolerability of multiple intravenous infusions of Ginkgolide B Injection in healthy Chinese participants, as well as to assess the pharmacokinetic (PK) characteristics following single and multiple doses.
Trial Details
NCT Number NCT07457008
Lead Sponsor West China Second University Hospital
Conditions Healthy Volunteers
Enrollment 36 participants
Start Date 2021-07-01
Primary Completion 2021-09-03 (estimated)
Study Completion 2021-09-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-09